Neostigmine ( DrugBank: Neostigmine )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 11 | Myasthenia gravis | 1 |
11. Myasthenia gravis
Clinical trials : 315 / Drugs : 232 - (DrugBank : 77) / Drug target genes : 46 - Drug target pathways : 126
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05091177 (ClinicalTrials.gov) | January 1, 2021 | 9/10/2021 | Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis | Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis | Ocular Myasthenia Gravis;Cytomegalovirus Infections | Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation | XiaoYong Liu | NULL | Recruiting | 18 Years | 50 Years | All | 125 | China |